Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids
- 30 June 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (6), 633-640
- https://doi.org/10.1016/s1081-1206(10)62291-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young childrenAnnals of Allergy, Asthma & Immunology, 1999
- Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroidsEuropean Respiratory Journal, 1998
- Chronic Asthma: An UpdatePediatrics in Review, 1996
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994
- Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic childrenRespiratory Medicine, 1994
- BudesonideDrugs, 1992
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled FlunisolideChest, 1992
- Compliance with inhaled therapy and morbidity from asthmaRespiratory Medicine, 1990